# Drug-drug Interaction Study of Aggrenox and Omeprazole in Normal Volunteers

> **NCT01303445** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 60 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Aggrenox alone
- **DRUG:** Aggrenox and omeprazole
- **DRUG:** Aggrenox and omeprazole
- **DRUG:** Omeprazole alone

## Key facts

- **NCT ID:** NCT01303445
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2011-04
- **Final completion:** —
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2013-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01303445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01303445, "Drug-drug Interaction Study of Aggrenox and Omeprazole in Normal Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01303445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*